143 related articles for article (PubMed ID: 14680472)
1. Antibody-based treatment of acute myeloid leukaemia.
Mulford DA; Jurcic JG
Expert Opin Biol Ther; 2004 Jan; 4(1):95-105. PubMed ID: 14680472
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for acute myeloid leukemia.
Jurcic JG
Curr Oncol Rep; 2005 Sep; 7(5):339-46. PubMed ID: 16091194
[TBL] [Abstract][Full Text] [Related]
3. Antibody therapy in acute myeloid leukemia: current status and future directions.
Burke JM; Jurcic JG
Clin Lymphoma; 2002 Mar; 2 Suppl 1():S12-8. PubMed ID: 11970765
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute leukaemias with monoclonal antibodies: current status and future prospects.
Leone G; Sica S; Voso MT; Rutella S; Pagano L
Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):33-52. PubMed ID: 16529548
[TBL] [Abstract][Full Text] [Related]
5. Ab therapy of AML: native anti-CD33 Ab and drug conjugates.
Jurcic JG
Cytotherapy; 2008; 10(1):7-12. PubMed ID: 17917880
[TBL] [Abstract][Full Text] [Related]
6. Antibody therapy of acute myelogenous leukemia.
Jurcic JG
Cancer Biother Radiopharm; 2000 Aug; 15(4):319-26. PubMed ID: 11041016
[TBL] [Abstract][Full Text] [Related]
7. Antibody therapy for residual disease in acute myelogenous leukemia.
Jurcic JG
Crit Rev Oncol Hematol; 2001 Apr; 38(1):37-45. PubMed ID: 11255080
[TBL] [Abstract][Full Text] [Related]
8. Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.
Amadori S; Stasi R
Curr Opin Hematol; 2008 Mar; 15(2):95-100. PubMed ID: 18300754
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic advances in neoplastic hematology: target therapy anti-CD33].
Di Rocco A; Finolezzi E; Anaclerico B; Calabrese E; Levi A; Trasarti S; Tafuri A
Clin Ter; 2005; 156(4):183-6. PubMed ID: 16342520
[TBL] [Abstract][Full Text] [Related]
10. The role of gemtuzumab ozogamicin in acute leukaemia therapy.
Tsimberidou AM; Giles FJ; Estey E; O'Brien S; Keating MJ; Kantarjian HM
Br J Haematol; 2006 Feb; 132(4):398-409. PubMed ID: 16412015
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias.
Jurcic JG; Caron PC; Nikula TK; Papadopoulos EB; Finn RD; Gansow OA; Miller WH; Geerlings MW; Warrell RP; Larson SM
Cancer Res; 1995 Dec; 55(23 Suppl):5908s-5910s. PubMed ID: 7493368
[TBL] [Abstract][Full Text] [Related]
12. Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676).
de Vetten MP; Jansen JH; van der Reijden BA; Berger MS; Zijlmans JM; Löwenberg B
Br J Haematol; 2000 Oct; 111(1):277-9. PubMed ID: 11091212
[TBL] [Abstract][Full Text] [Related]
13. Antibody immunotherapy for leukemia.
Jurcic JG
Curr Oncol Rep; 2000 Mar; 2(2):114-22. PubMed ID: 11122832
[TBL] [Abstract][Full Text] [Related]
14. Antibody-targeted therapy for myeloid leukemia.
Appelbaum FR
Semin Hematol; 1999 Oct; 36(4 Suppl 6):2-8. PubMed ID: 10530710
[TBL] [Abstract][Full Text] [Related]
15. Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT.
Swords R; Hayden PJ; Molloy K; Lawlor M; Browne PV; Murphy PT
Eur J Haematol; 2004 Dec; 73(6):450-1. PubMed ID: 15522070
[No Abstract] [Full Text] [Related]
16. Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.
Rosenblat TL; McDevitt MR; Mulford DA; Pandit-Taskar N; Divgi CR; Panageas KS; Heaney ML; Chanel S; Morgenstern A; Sgouros G; Larson SM; Scheinberg DA; Jurcic JG
Clin Cancer Res; 2010 Nov; 16(21):5303-11. PubMed ID: 20858843
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies and immunoconjugates in acute myeloid leukemia.
Amadori S; Stasi R
Best Pract Res Clin Haematol; 2006; 19(4):715-36. PubMed ID: 16997179
[TBL] [Abstract][Full Text] [Related]
18. Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias.
Burke JM; Caron PC; Papadopoulos EB; Divgi CR; Sgouros G; Panageas KS; Finn RD; Larson SM; O'Reilly RJ; Scheinberg DA; Jurcic JG
Bone Marrow Transplant; 2003 Sep; 32(6):549-56. PubMed ID: 12953125
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse.
Sievers EL
Expert Opin Biol Ther; 2001 Sep; 1(5):893-901. PubMed ID: 11728223
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy for hematopoietic cell transplantation.
Jurcic JG
Immunotherapy; 2013 Apr; 5(4):383-94. PubMed ID: 23557421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
